Susan Blum
Director of Finance/CFO chez MELINTA THERAPEUTICS, INC.
Profil
Susan Blum is an Independent Director at BiomX, Inc. since 2024.
She also serves as the Chief Financial Officer at Melinta Therapeutics, Inc. since 2016.
Previously, she worked as a Controller at Textura Corp.
from 2013 to 2016.
Ms. Blum completed her undergraduate degree at Santa Clara University.
Postes actifs de Susan Blum
| Sociétés | Poste | Début |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Director of Finance/CFO | 01/01/2016 |
| BIOMX INC. | Director/Board Member | 11/04/2024 |
Anciens postes connus de Susan Blum
| Sociétés | Poste | Fin |
|---|---|---|
| TEXTURA CORP | Comptroller/Controller/Auditor | 01/01/2016 |
Formation de Susan Blum
| Santa Clara University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOMX INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Textura Corp.
 Textura Corp. Internet Software/ServicesTechnology Services Textura Corp. engages in the provision of on-demand business collaboration software to the commercial construction industry. The company was founded by William H. Eichhorn and Patrick J. Allin in September 2004 and is headquartered in Austin, TX. | Technology Services |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
